NOVEOS is an allergy testing system that fuses "proven technologies with innovative methodologies," ultimately reimagining the way we check for allergies. The device is developed by HYCOR -- a California-based company, and it promises efficiency, reduction of operational costs and hyper-accurate results.
NOVEOS operates with "microparticles and chemiluminescence, with help from liquid ready-to-go reagent."Moreover, the allergy testing system is more "resistant to blood-based interference" than its predecessors. The NOVEOS also decreases the need for human labor as it can efficiently work for up to eight hours without interference. HYCOR has also ensured that the allergy testing system boasts increased onboard loading capacity, with the ability to process up to 140 allergens and up to 10,500 allergen tests at one time. There is a total of 60 positions for patient samples, as well.
Photo Credits: HYCOR
FDA-Approved Allergy Testing Systems
NOVEOS Provides Accurate Results with Small Sample Sizes
Trend Themes
1. Advanced Allergy Testing - NOVEOS allergy testing system reimagines how allergies are checked, providing accurate results with small sample sizes.
2. Efficiency in Healthcare Testing - NOVEOS promises efficiency and reduction of operational costs by decreasing the need for human labor and increasing loading capacity.
3. Improved Testing Technology - NOVEOS utilizes microparticles and chemiluminescence, with ready-to-go reagent, to improve accuracy and reduce interference.
Industry Implications
1. Healthcare - NOVEOS allergy testing system can disrupt the healthcare industry by streamlining allergy testing processes and providing accurate results.
2. Medical Devices - NOVEOS represents an innovation opportunity in the medical devices industry through its advanced allergy testing technology and increased efficiency.
3. Diagnostic Testing - NOVEOS showcases disruptive innovation for diagnostic testing by improving the accuracy and efficiency of allergy tests.